A second-generation molecular clamp stabilised bivalent candidate vaccine for protection against diseases caused by respiratory syncytial virus and human metapneumovirus
Young, Andrew, Kolekar, Sharada, Alvarez Mendoza, Carlos, Jaberolansar, Noushin, Modhiran, Naphak, Webb, Tim, McCuaig, Robert, Kommajosyula, Varsha, Tardiota, Nicolas, Dy, Quimbe, Amarilla, Alberto A., Dalrymple, Rhiannon L., Gillard, Marianne, Dutton, Julie L., Magdalena, Juana, Vandendriessche, Frank, Smal, Jean, Young, Paul R., Watterson, Daniel, Hanon, Emmanuel J. and Chappell, Keith J. (2025). A second-generation molecular clamp stabilised bivalent candidate vaccine for protection against diseases caused by respiratory syncytial virus and human metapneumovirus. PLOS Pathogens, 21 (7) e1013312, e1013312-7. doi: 10.1371/journal.ppat.1013312
HTLV-1 reverse transcriptase homology model provides structural basis for sensitivity to existing nucleoside/nucleotide reverse transcriptase inhibitors
Tardiota, Nicolas, Jaberolansar, Noushin, Lackenby, Julia A., Chappell, Keith J. and O’Donnell, Jake S. (2024). HTLV-1 reverse transcriptase homology model provides structural basis for sensitivity to existing nucleoside/nucleotide reverse transcriptase inhibitors. Virology Journal, 21 (1) 14, 14. doi: 10.1186/s12985-024-02288-z
